Interesting IMVT Put Options For November 21st

The article highlights a strategy involving selling a $15.00 strike put option on Immunovant (IMVT) for 60 cents, with the stock currently at $15.15. This trade offers investors a potential effective acquisition cost of $14.40 per share, a discount to the market price. Should the option expire worthless, which has a 55% probability, the premium yields a 24.32% annualized return on the committed capital, presenting an attractive income generation opportunity for those bullish on IMVT.

Analysis

The analysis centers on an options-based strategy for Immunovant Inc. (IMVT), specifically selling a cash-secured put with a $15.00 strike price for a 60-cent premium while the stock trades at $15.15. This trade presents two primary outcomes for an investor already interested in the stock. Firstly, should the stock price fall to or below $15.00 at expiration, the investor acquires shares at an effective cost basis of $14.40, a discount to the current market price. Secondly, if IMVT remains above $15.00, the option is projected to expire worthless with a 55% probability, allowing the investor to retain the premium for a 4.00% return on capital, which annualizes to a significant 24.32%. A key driver for this high potential yield is the option's implied volatility of 63%, which stands notably above the stock's trailing twelve-month historical volatility of 53%. This volatility premium indicates that the market is pricing in greater future price swings than observed historically, thereby inflating the option premium and enhancing the potential return for the seller.

Key Decisions for Investors

• Investors bullish on IMVT could consider selling this put as a disciplined strategy to either acquire the stock at an effective cost of $14.40 or to generate a high-yield income while waiting for a potential entry point.
• Income-oriented investors may find the 24.32% annualized yield compelling, but must be comfortable with the obligation to purchase IMVT shares and the associated equity risk if the stock declines below the strike price.
• Given that implied volatility (63%) exceeds historical volatility (53%), investors should weigh the attractive premium against the market's expectation of increased price fluctuation and the corresponding 45% probability of being assigned the stock.